REGULATION OF GENE EXPRESSION BY DIETARY FAT
膳食脂肪对基因表达的调节
基本信息
- 批准号:2146177
- 负责人:
- 金额:$ 9.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 1998-07-31
- 项目状态:已结题
- 来源:
- 关键词:dietary lipid enzyme inhibitors gene expression genetic promoter element genetic regulatory element genetic transcription glucose 6 phosphate dehydrogenase laboratory mouse liver cells messenger RNA nuclear runoff assay nucleic acid probes nucleic acid repetitive sequence nutrition related tag polymerase chain reaction posttranscriptional RNA processing restriction mapping tissue /cell culture transfection unsaturated fatty acids
项目摘要
The long-term objective of this work is to understand the molecular
mechanism by which dietary polyunsaturated fats inhibit gene expression.
Americans are encouraged to consume less fat and a higher polyunsaturated
to saturated fat ratio. This recommended dietary goal is a preventive
health measure because of the correlation between fat intake, serum lipids
and the risk of heart disease. Little is known about the intracellular
events resulting from changing the type and quantity of fat in the diet.
Polyunsaturated fatty acids have a myriad of actions within the organism
including the transcriptional regulation of a number of genes. However,
the mechanisms by which fatty acids alter gene expression remain to be
determined. Glucose-6-phosphate dehydrogenase (G6PD) is inhibited both by
dietary polyunsaturated fats and by polyunsaturated fatty acids in
hepatocytes in culture. Consequently, G6PD will be used as our model gene.
The research program described in this application will determine if the
inhibition of G6PD by polyunsaturated fatty acids occurs at a pre- or
post-transcriptional step and then to determine the molecular basis by
which this inhibition occurs. In Specific Aim 1, the genomic DNA probes
will be characterized and a cDNA generated for the analysis of
transcriptional activity and mRNA accumulation. Only probes which are free
of repetitive elements and unique with respect of their occurrence within
the genome will be used. In Specific Aim 2, the relative importance of
transcriptiona1 versus post-transcriptional processes on the regulation of
G6PD by dietary fat will be determined. Mice fed a high glucose, low fat
diet will be compared to mice fed a high glucose diet supplemented with
safflower oil. Transcriptional activity will be measured using the nuclear
run-on assay and compared with changes in the accumulation of G6PD mRNA
and activity of the enzyme. In Specific Aim 3, the molecular level at
which fatty acids inhibit G6PD expression in hepatocytes will be
determined. Transcriptional activity, mRNA abundance and enzyme activity
will be compared in primary cultures of mouse hepatocyte+/- linoleate and
arachidonate. In Specific Aim 4, the molecular basis for the inhibition of
G6PD expression by fatty acids will be determined. If regulation is
primarily transcriptional, the cis-acting DNA element in the G6PD 5'-
flanking DNA will be identified using DNase I hypersensitivity assays,
functional transfection analyses of deletion mutants and in vitro DNA
binding assays. If regulation is post-transcriptional, the precise step
will be localized and the cis-acting element within the mRNA sequences
will be identified using functional transfection analyses of G6PD RNA
sequences linked to a reporter gene. In both cases the putative response
element will be characterized for its ability to confer fatty acid
regulation on a heterologous promoter or gene and will be defined by
sequence specific mutations.
这项工作的长期目标是了解分子
膳食多不饱和脂肪抑制基因表达的机制。
美国人被鼓励消耗更少的脂肪和更高的多不饱和脂肪酸。
饱和脂肪的比例。这一建议的饮食目标是预防
由于脂肪摄入量、血清脂质
和患心脏病的风险。对细胞内的
由于改变饮食中脂肪的类型和数量而导致的事件。
多不饱和脂肪酸在生物体内有无数的作用
包括许多基因的转录调控。然而,在这方面,
脂肪酸改变基因表达的机制仍然是
测定葡萄糖-6-磷酸脱氢酶(G6 PD)被抑制,
膳食中的多不饱和脂肪和多不饱和脂肪酸
培养的肝细胞。因此,G6 PD将被用作我们的模型基因。
本申请中描述的研究计划将确定
多不饱和脂肪酸对G6 PD的抑制作用发生在
转录后步骤,然后确定分子基础,
这种抑制发生。在特定目标1中,基因组DNA探针
将被表征并产生cDNA用于分析
转录活性和mRNA积累。仅适用于空闲的探头
重复的元素和独特的,就其出现在
将使用基因组。在具体目标2中,
转录1与转录后过程对调节
将通过膳食脂肪测定G6 PD。老鼠被喂食高葡萄糖,低脂肪
饮食将与喂食补充有以下物质的高葡萄糖饮食的小鼠进行比较
红花油转录活性将使用细胞核来测量
连续试验,并与G6 PD mRNA积累的变化进行比较
和酶的活性。在具体目标3中,
哪种脂肪酸抑制肝细胞中G6 PD的表达,
测定转录活性、mRNA丰度和酶活性
将在小鼠肝细胞+/-亚油酸酯和
花生四烯酸在具体目标4中,
将测定脂肪酸的G6 PD表达。如果调控
主要是转录,顺式作用的DNA元件在G6 PD 5 '-
侧翼DNA将使用DNase I超敏性测定来鉴定,
缺失突变体和体外DNA的功能转染分析
结合测定。如果调控是转录后的,
mRNA序列中的顺式作用元件
将使用G6 PD RNA的功能转染分析来鉴定
与报告基因相连的序列。在这两种情况下,
元素的特征在于其赋予脂肪酸
在异源启动子或基因上的调节,并且将被定义为
序列特异性突变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA M SALATI其他文献
LISA M SALATI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA M SALATI', 18)}}的其他基金
Nutrient Control of Gene Expression & Cell Signaling
基因表达的营养控制
- 批准号:
7603062 - 财政年份:2005
- 资助金额:
$ 9.99万 - 项目类别:
Nutrient Control of Gene Expression & Cell Signaling
基因表达的营养控制
- 批准号:
7232760 - 财政年份:2005
- 资助金额:
$ 9.99万 - 项目类别:
Nutrient Control of Gene Expression & Cell Signaling
基因表达的营养控制
- 批准号:
7406065 - 财政年份:2005
- 资助金额:
$ 9.99万 - 项目类别:
相似海外基金
Developing multitarget enzyme inhibitors as safe and effective anti-migraine treatments
开发多靶点酶抑制剂作为安全有效的抗偏头痛治疗方法
- 批准号:
10714658 - 财政年份:2023
- 资助金额:
$ 9.99万 - 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10395608 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10576908 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
- 批准号:
RGPIN-2017-04233 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Discovery Grants Program - Individual
Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci
葡萄球菌先天免疫逃避库中的新型酶抑制剂
- 批准号:
10166534 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Novel Enzyme Inhibitors in the Immune Evasion Repertoire of Staphylococcus aureus (Equipment Supplement)
金黄色葡萄球菌免疫逃逸的新型酶抑制剂(设备补充)
- 批准号:
10796329 - 财政年份:2021
- 资助金额:
$ 9.99万 - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10259832 - 财政年份:2020
- 资助金额:
$ 9.99万 - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10642850 - 财政年份:2020
- 资助金额:
$ 9.99万 - 项目类别:
The Development and Study of Novel Lipopeptide Antibiotics and Enzyme Inhibitors
新型脂肽抗生素和酶抑制剂的开发与研究
- 批准号:
RGPIN-2017-04233 - 财政年份:2020
- 资助金额:
$ 9.99万 - 项目类别:
Discovery Grants Program - Individual
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10408178 - 财政年份:2020
- 资助金额:
$ 9.99万 - 项目类别: